MetLife Investment Management
MDXG icon

MetLife Investment Management’s MiMedx Group MDXG Stock Holding History

MetLife Investment Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
73,321
+19,330
+36% +$70.5K ﹤0.01% 2245
2026
Q1 		$213K Sell
53,991
-10,819
-17% -$54.5K ﹤0.01% 2190
2025
Q4 		$439K Sell
64,810
-6,185
-9% -$43.4K ﹤0.01% 1854
2025
Q3 		$496K Hold
70,995
– – ﹤0.01% 1811
2025
Q2 		$434K Buy
70,995
+2,233
+3% +$14.9K ﹤0.01% 1743
2025
Q1 		$523K Sell
68,762
-4,544
-6% -$38K ﹤0.01% 1706
2024
Q4 		$705K Buy
73,306
+6,673
+10% +$52K ﹤0.01% 1603
2024
Q3 		$394K Hold
66,633
– – ﹤0.01% 1910
2024
Q2 		$462K Buy
66,633
+11,901
+22% +$83.7K ﹤0.01% 1759
2024
Q1 		$421K Sell
54,732
-5,261
-9% -$42.3K ﹤0.01% 1772
2023
Q4 		$526K Hold
59,993
– – ﹤0.01% 1659
2023
Q3 		$437K Hold
59,993
– – ﹤0.01% 1712
2023
Q2 		$397K Hold
59,993
– – ﹤0.01% 1855
2023
Q1 		$205K Buy
59,993
+11,153
+23% +$43.2K ﹤0.01% 2209
2022
Q4 		$136K Sell
48,840
-13,023
-21% -$38.9K ﹤0.01% 2464
2022
Q3 		$178K Buy
61,863
+7,298
+13% +$25.9K ﹤0.01% 2372
2022
Q2 		$189K Sell
54,565
-8,246
-13% -$32.3K ﹤0.01% 2360
2022
Q1 		$296K Buy
62,811
+22,593
+56% +$110K ﹤0.01% 2105
2021
Q4 		$243K Buy
40,218
+13,960
+53% +$96.9K ﹤0.01% 1940
2021
Q3 		$159K Sell
26,258
-14,876
-36% -$168K ﹤0.01% 2225
2021
Q2 		$515K Buy
+41,134
New +$445K ﹤0.01% 1550
2018
Q4 		– Sell
-48,233
Closed -$298K – 2585
2018
Q3 		$298K Hold
48,233
– – ﹤0.01% 1860
2018
Q2 		$308K Hold
48,233
– – ﹤0.01% 1706
2018
Q1 		$336K Hold
48,233
– – ﹤0.01% 1622
2017
Q4 		$608K Buy
+48,233
New +$588K 0.01% 1291

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Paradigm Capital Management Inc
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MetLife Investment Management's MDXG Position: Q2 2026 in Review

MetLife Investment Management increased its MiMedx Group (MDXG) stake by 36% in Q2 2026, buying an estimated $70.5K and bringing the position to 73,321 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

MetLife Investment Management first reported a position in MDXG in Q4 2017 and has held it in 25 quarters since. The position peaked at $705K in Q4 2024. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • MetLife Investment Management held 73,321 shares of MiMedx Group worth $282K as of Q2 2026.
  • MetLife Investment Management bought 19,330 MiMedx Group shares in Q2 2026, an estimated $70.5K.
  • MiMedx Group made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2245 holding.
  • MetLife Investment Management first reported a position in MiMedx Group in Q4 2017 and has held it in 25 quarters since.
  • MetLife Investment Management's MiMedx Group position peaked at $705K in Q4 2024.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.